Amarin Corporation plc (AMRN) announced it received a Decision to Grant from the European Patent Office for a new patent covering VAZKEPA that will extend VAZKEPA exclusivity eight additional years into 2039. Also, the company recently achieved success defending a separate European VAZKEPA patent from third-party opposition within the EPO.
Patrick Holt, President & CEO, Amarin, said: "Moving forward, we will continue to rigorously defend our IP rights and explore any possibilities to strengthen Amarin's patents and patent families around the world."
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.